首页> 外文期刊>Modern pathology >Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group
【24h】

Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group

机译:推进肿瘤病理学研究报告:世界卫生组织按肿瘤类型组划分的肿瘤分类活证据差距图的病理学家指南

获取原文
获取原文并翻译 | 示例

摘要

Evidence-based medicine (EBM) can be an unfamiliar territory for those working in tumor pathology research, and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, reviewed and endorsed by the Word Health Organization International Agency for Research on Cancer 's International Collaboration for Cancer Classi fication and Research, we aim to help pathologists and researchers understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these. We introduce some basic EBM concepts, a framework for research questions, and thoughts on study design and emphasize the concept of reporting standards. There are many study-speci fic reporting guidelines available, and we provide an overview of these. However, existing reporting guidelines perhaps do not always fi t tumor pathology research papers, and hence, here, we collate the key reporting data set together into one generic checklist that we think will simplify the task for pathologists. The article aims to complement our recent hierarchy of evidence for tumor pathology and glossary of evidence (study) types in tumor pathology. Together, these articles should help any researcher get to grips with the basics of EBM for planning and publishing research in tumor pathology, as well as encourage an improved standard of the reports available to us all in the literature. (c) 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States Canadian Academy of Pathology. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
机译:对于从事肿瘤病理学研究的人来说,循证医学 (EBM) 可能是一个陌生的领域,并且如何采用 EBM 方法来规划和报告基于组织病理学的研究存在很大的不确定性。在本文中,由世界健康组织国际癌症研究机构的癌症分类和研究国际合作审查和认可,我们旨在帮助病理学家和研究人员了解规划循证肿瘤病理学研究的基础知识,以及我们关于如何报告这些结果的建议。我们介绍了一些基本的循证医学概念、研究问题的框架和对研究设计的想法,并强调了报告标准的概念。有许多针对特定研究的报告指南可用,我们提供了这些指南的概述。然而,现有的报告指南可能并不总是适合肿瘤病理学研究论文,因此,在这里,我们将关键报告数据集整理成一个通用清单,我们认为这将简化病理学家的任务。本文旨在补充我们最近的肿瘤病理学证据层次结构和肿瘤病理学证据(研究)类型词汇表。总之,这些文章应该可以帮助任何研究人员掌握 EBM 的基础知识,以规划和发表肿瘤病理学研究,并鼓励提高文献中提供给我们的报告的标准。(c) 2024 作者。由Elsevier Inc.代表美国和加拿大病理学学会出版。这是一篇采用 CC BY 许可证(http://creativecommons.org/ licenses/by/4.0/)的开放获取文章。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号